Usefulness of Midregional Proadrenomedullin to Predict Poor Outcome in Patients with Community Acquired Pneumonia

BACKGROUND: midregional proadrenomedullin (MR-proADM) is a prognostic biomarker in patients with community-acquired pneumonia (CAP). We sought to confirm whether MR-proADM added to Pneumonia Severity Index (PSI) improves the potential prognostic value of PSI alone, and tested to what extent this com...

Descripción completa

Detalles Bibliográficos
Autores principales: Gordo-Remartínez, Susana, Calderón-Moreno, María, Fernández-Herranz, Juan, Castuera-Gil, Ana, Gallego-Alonso-Colmenares, Mar, Puertas-López, Carolina, Nuevo-González, José A., Sánchez-Sendín, Domingo, García-Gámiz, Mercedes, Sevillano-Fernández, José A., Álvarez-Sala, Luis A., Andueza-Lillo, Juan A., de Miguel-Yanes, José M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452655/
https://www.ncbi.nlm.nih.gov/pubmed/26030588
http://dx.doi.org/10.1371/journal.pone.0125212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452655/
https://www.ncbi.nlm.nih.gov/pubmed/26030588
http://dx.doi.org/10.1371/journal.pone.0125212

Ejemplares similares